Martin Zweig Detailed Fundamental Analysis

Validea's guru fundamental report rates Cooper Companies (COO), a large-cap medical equipment stock, at 62% using Martin Zweig's Growth Investor model, falling below the 80% threshold for strategic interest. Despite passing on valuation, current earnings, and debt, COO failed key growth criteria including sales growth rate, earnings persistence, and long-term EPS growth, suggesting it does not fully align with the accelerating growth profile central to Zweig's historically successful strategy.

Analysis

According to a Validea fundamental report, Cooper Companies Inc. (COO) scores a 62% based on the Martin Zweig growth investor model, a rating that falls below the 80% threshold typically indicating strategic interest. The analysis presents a mixed fundamental picture for the large-cap medical equipment firm. On the positive side, COO passes on key valuation and stability metrics, including its P/E ratio, a low total debt-to-equity ratio, and favorable insider transaction activity. Current earnings metrics are also strong, with positive growth over the prior year. However, the company fails on several critical growth and momentum indicators central to the Zweig strategy. Specifically, it did not pass the tests for sales growth rate, long-term EPS growth, and earnings persistence. A significant flag is the failure of current quarter EPS growth to accelerate beyond the rate of the prior three quarters, suggesting a potential plateau in momentum despite being positive.

Key Decisions for Investors

• Dedicated growth investors should be cautious, as the analysis indicates COO currently lacks the accelerating sales and earnings momentum required by a stringent growth model like Zweig's.
• Investors with a 'growth at a reasonable price' (GARP) mandate may find the combination of a passing valuation, low debt, and positive current earnings warrants further diligence, despite the lack of acceleration.
• Closely monitor upcoming quarterly results for a turnaround in the flagged weaknesses, specifically the overall sales growth rate and a re-acceleration of sequential EPS growth, which are the primary drags on its model score.